Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Organic Chemistry|January 10, 1997
Synthesis of Linear and Angular Triquinane Skeletons by O-Stannyl Ketyl-Promoted Fragmentation-Cyclization Reactions of alpha-Keto CyclopropanesEric J. Enholm, Zhaozhong J. Jia
Bioorganic & Medicinal Chemistry Letters|March 20, 2009
Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SARPenglie Zhang, Liang Bao, Jingmei Fan, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Inhibitory effect of carboxylic acid group on hERG bindingBing-Yan Zhu, Zhaozhong J Jia, Penglie Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamidesZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2011
Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritisGreg Coffey, Francis DeGuzman, Mayuko Inagaki, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activityPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 2: A survey of P4 motifsZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifsPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitorsZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2003
Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitorsUma Sinha, Pei Hua Lin, Susan T Edwards, et al.
Pageof 2